Ovarian Cancer Perspective

• Gynecologic Cancer Studies: What to Look for at ASCO 2022   It's not just about ovarian cancer anymore -- presentations at ASCO 2022 illustrate the major advances that have been made in gynecologic cancer treatments.
  Medscape Oncology, May 20, 2022
• Episode 4: The Impact of BRCA Status on Therapy Choices   Drs Lidia Schapira and Nadine Tung discuss how BRCA status affects choosing therapy for patients with early-stage breast cancer.
  Medscape, April 12, 2022
• Episode 2: DCIS and Low-Risk, Early-Stage Breast Cancer   Drs Lidia Schapira and Antonio Wolff discuss the current research on DCIS and other forms of lower-risk early breast cancer, and how medical oncologists can work to create an optimal treatment plan.
  Medscape, March 15, 2022
• Doc Says Crying Attorney Led to Unfair Million $$$ Verdict Did a crying attorney taint the jury's decision?
  February 24, 2022
• The Symptoms of Early-Stage Ovarian Cancer   Contrary to what many have learned, early-stage ovarian cancer often presents with symptoms, providing the potential for earlier diagnosis of this frequently lethal condition.
  Medscape Ob/Gyn, February 08, 2022
• Physicians of the Year 2021: Best and Worst Physicians and other healthcare workers continued to fight COVID-19 and tackled other pertinent issues in medicine including racism, mental illness, and gender bias. However, with the good comes the bad.
  Medscape News Slideshows, December 17, 2021
• Do the COVID-19 Vaccines Really Increase MI Risk? A new "study" claimed a dramatic rise in cardiac risk after COVID-19 vaccination. But this conference abstract has a few problems, not the least of which is its reliance on surrogate endpoints.
  Medscape Blogs, December 09, 2021
• LGBTQ Healthcare: There Is Reason to Be Hopeful Don Dizon, MD, and Michelle Forcier, MD, MPH, discuss the gaps in treating LGBTQ individuals, and how we can meet their healthcare needs.
  Medscape Oncology, December 06, 2021
• A 27-Year-Old Woman With Pelvic Pain Explore histological findings in a 27-year-old woman who presents to her gynecologist with a 4-month history of pelvic pain and metrorrhagia.
  Osmosis, November 26, 2021
• ASCO 2021 ASCO Data Confirm Standard of Care for Cervical, Ovarian Cancer   Dr Maurie Markman describes two large phase 3 trials that 'clearly establish' the existing standard of care for cervical and ovarian cancer.
  Medscape Oncology, July 09, 2021
• Ovarian Cancer Management: We Have Come So Far   Gynecologic oncologist Dr Shannon Westin considers how far ovarian cancer management has come since she was in medical school, and speaks to the areas that still need to be addressed.
  Medscape, June 29, 2021
• Two Mentors Who Shaped an Oncologist's Approach to Ovarian Cancer   Gynecologic oncologist Dr Shannon Westin reflects on valuable techniques and insights she gained from two mentors who shaped her approach to ovarian cancer.
  Medscape, June 28, 2021
• The Two Greatest Challenges in Managing Ovarian Cancer   Gynecologic oncologist Dr Shannon Westin reveals her two greatest challenges when facing patients with ovarian cancer: early detection and finding the right treatment for the right patient.
  Medscape, June 25, 2021
• Reflections on the Evolution of Ovarian Cancer Guidelines   Dr Robert Coleman recalls his fellowship and how ovarian cancer clinical practice guidelines changed practically overnight.
  Medscape, June 15, 2021
• ASCO 2021 Olaparib Beneficial for BRCA-Mutated HER2-Negative Breast Cancer   Dr Kathy Miller shares the 'biggest news in the breast cancer world' from ASCO, with presented data showing the benefit of olaparib in patients with high-risk, BRCA-mutated HER2-negative disease.
  Medscape Oncology, June 11, 2021
• An Ovarian Cancer Expert Looks Back to Residency   Dr Coleman reflects on his first experiences with ovarian cancer patients.
  Medscape, May 13, 2021
• Oral Contraceptives and Cancer: New Data   Dr Andrew Kaunitz breaks down a new study that examines the link between oral contraceptives and cancer.
  Medscape Ob/Gyn, January 27, 2021
• Population Testing for Hereditary Breast and Ovarian Cancer Worthwhile?   Andrew Kaunitz doesn't plan to change his practice related to hereditary cancer screening in women -- yet.
  Medscape Ob/Gyn, December 24, 2020
• Any Merit to Quercetin's Anticancer Claims? As the use of quercetin for preventing cancer grows in popularity, it may not yet be borne out by the data.
  Medscape Oncology, October 22, 2020
• Highlights in Ovarian Cancer From ESMO 2020   Dr Susana Banerjee reports on key ovarian cancer presentations from ESMO 2020, including the eagerly awaited SOLO1 5-year follow-up, patient outcomes from PRIMA, and results of the PAOLA-1 study.
  Medscape, October 12, 2020